|
AHCYL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.82887038846502E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.66444635851803E-12 |
| Normal-vs-Stage2 |
2.560200E-03 |
| Normal-vs-Stage3 |
8.247100E-04 |
| Normal-vs-Stage4 |
7.929800E-02 |
| Stage1-vs-Stage2 |
1.180580E-01 |
| Stage1-vs-Stage3 |
1.968210E-01 |
| Stage1-vs-Stage4 |
1.406360E-01 |
| Stage2-vs-Stage3 |
7.891000E-01 |
| Stage2-vs-Stage4 |
8.129000E-01 |
| Stage3-vs-Stage4 |
6.706600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.74649184003783E-12 |
| Normal-vs-AfricanAmerican |
1.7702994625779E-10 |
| Normal-vs-Asian |
1.866580E-01 |
| Caucasian-vs-AfricanAmerican |
7.017600E-01 |
| Caucasian-vs-Asian |
6.184800E-01 |
| AfricanAmerican-vs-Asian |
7.099400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.88657986402541E-15 |
| Normal-vs-Female |
9.77020000000328E-05 |
| Male-vs-Female |
2.560200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.6443000051587E-08 |
| Normal-vs-Extreme_Weight |
6.66133814775094E-16 |
| Normal-vs-Obese |
1.36150000051849E-07 |
| Normal-vs-Extreme_Obese |
3.439200E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.385590E-01 |
| Normal_Weight-vs-Obese |
6.407000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.967200E-01 |
| Extreme_Weight-vs-Obese |
3.319500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.114800E-01 |
| Obese-vs-Extreme_Obese |
7.899400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.590200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.03492778183545E-12 |
| Normal-vs-Age(61-80Yrs) |
2.65343302885412E-14 |
| Normal-vs-Age(81-100Yrs) |
4.70990000334126E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.681030E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.194410E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.238770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.455200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.410600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.235600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62458935193399E-12 |
| Normal-VS-Type2 PRCC |
4.79149997456574E-09 |
| Normal-VS-KIRP CIMP |
5.345400E-01 |
| Normal-VS-Unclassified PRCC |
2.14419999977622E-07 |
| Type1 PRCC-VS-Type2 PRCC |
5.450400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.504020E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.753600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.663800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.047400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.783800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.56570378463084E-11 |
| Normal-vs-N1 |
2.890200E-02 |
| Normal-vs-N2 |
3.484800E-01 |
| N0-vs-N1 |
1.370750E-01 |
| N0-vs-N2 |
3.380000E-01 |
| N1-vs-N2 |
9.862000E-01 |
|
|
